New chemo combo after radiation shows promise for advanced cervical cancer

NCT ID NCT04016142

Terminated Disease control Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether adding a specific chemotherapy combination (carboplatin and paclitaxel) after standard chemoradiation could help people with advanced cervical cancer that has spread to lymph nodes near the kidneys. The trial planned to enroll 21 participants but was stopped early. The goal was to see if the extra chemo could delay cancer progression and improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER LOCALLY ADVANCED CANCER

Contacts and locations

Locations

Centre Hospitalier de Lens

Lens, France
Centre Léonard de Vinci

Dechy, France, France
Centre Marie Curie

Arras, France, France
Centre Oscar Lambret

Lille, France, France
Centre Pierre Curie

Beuvry, France, France
Clinique des dentellières

Valenciennes, France, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.